RAD 2652 PRE

If a patient tumor receives a dose of 250 cGy/day at 79.9% PDD, what is the dose at dmax for this treatment?
Click the card to flip 👆
1 / 20
Terms in this set (20)
The regional lymph nodes in breast cancer are: A) The internal mammary, supraclavicular and axillary B) ? C) The internal mammary, supraclavicular, and inguinal D) The internal mammary, supraclavicular, and aorticA) The internal mammary, supraclavicular and axillaryA lung boost is often delivered via: A) Opposed lateral fields B) Opposed oblique fields C) Single oblique fields D) Opposed anterior-posterior fields, and an oblique electron fieldB) Opposed oblique fieldsThe formula for field divergence, shown here, is used to determine the number of degrees that the _________________. tan^-1 = Half cranial field length/SSD A) Couch must rotated for craniospinal field B) Collimator must be turned for a craniospinal field C) Collimator is turned for a 3 field breast treatment D) Couch angle must be turned for a 2 field treatmentA) Couch must rotated for craniospinal fieldA boost dose is to be delivered to a soft tissue sarcoma tumor bed at a depth of 3 cm, the prescription states that 200 cGy/fx be given to the 90% isodose line. The appropriate electron energy used in this case would be? A) 10 MeV B) 12 MeV C) 13 MeV D) 18 MeVB) 12 MeV (E/4 = depth of the 90% isodose line)A suitable wedge angle for two fields separated by 90 degrees is: A) 15 B) 30 C) 45 D) 60C) 45 degrees (Wedge = (180-Hinge)/2)A target volume that includes the CTV with additional margin of 0.5 cm to allow for patient movement and setup error is termed the A) GTV B) CTV C) ITV D) PTVD) PTVAn advantage of SAD setup techniques verses SSD setup techniques is: A) The gantry remains at 90 degrees B) Patients do not have to be moved between gantry angles C) Patients are moved between changes in gantry angles D) The gantry remains at 180 degreesB) Patients do not have to be moved between gantry anglesTAR at the depth of Dmax corrrects for scatter of dose which is the same as: A) SAR B) TPR C) BSF D) PPDC) BSFTD 5/5 means: A) 5% change of complications at 5 Gy B) 5% of complications in 5 out of 5 patients C) 5% chance of complications at 50 cGy D) 5% chance of complications in 5 yearsD) 5% chance of complications in 5 yearsWhen planning a gynecologic implant, the treatment dose is calculated to Point ____ A) A B) B C) C D) DA) A